1. Giakountis, Antonis, Moulos, Panagiotis, Sarris, Michalis E, Hatzis, Pantelis, Talianidis, Iannis. 2016. Smyd3-associated regulatory pathways in cancer. In Seminars in cancer biology, 42, 70-80. doi:10.1016/j.semcancer.2016.08.008. https://pubmed.ncbi.nlm.nih.gov/27554136/
2. Ikram, Sabeen, Rege, Apurv, Negesse, Maraki Y, Reynoird, Nicolas, Green, Erin M. 2023. The SMYD3-MAP3K2 signaling axis promotes tumor aggressiveness and metastasis in prostate cancer. In Science advances, 9, eadi5921. doi:10.1126/sciadv.adi5921. https://pubmed.ncbi.nlm.nih.gov/37976356/
3. Nigam, Nupur, Bernard, Benjamin, Sevilla, Samantha, Hager, Gordon L, Saloura, Vassiliki. 2023. SMYD3 represses tumor-intrinsic interferon response in HPV-negative squamous cell carcinoma of the head and neck. In Cell reports, 42, 112823. doi:10.1016/j.celrep.2023.112823. https://pubmed.ncbi.nlm.nih.gov/37463106/
4. Yang, Yang, Qiu, Rongfang, Zhao, Siyu, Chen, Minjiang, Ji, Jiansong. 2022. SMYD3 associates with the NuRD (MTA1/2) complex to regulate transcription and promote proliferation and invasiveness in hepatocellular carcinoma cells. In BMC biology, 20, 294. doi:10.1186/s12915-022-01499-6. https://pubmed.ncbi.nlm.nih.gov/36575438/
5. Yang, Zongcheng, Liu, Fen, Li, Zongkai, Zheng, Lixin, Zhang, Zhihong. 2023. Histone lysine methyltransferase SMYD3 promotes oral squamous cell carcinoma tumorigenesis via H3K4me3-mediated HMGA2 transcription. In Clinical epigenetics, 15, 92. doi:10.1186/s13148-023-01506-9. https://pubmed.ncbi.nlm.nih.gov/37237385/
6. Agborbesong, Ewud, Zhou, Julie Xia, Zhang, Hongbing, Calvet, James P, Li, Xiaogang. 2024. SMYD3 Controls Ciliogenesis by Regulating Distinct Centrosomal Proteins and Intraflagellar Transport Trafficking. In International journal of molecular sciences, 25, . doi:10.3390/ijms25116040. https://pubmed.ncbi.nlm.nih.gov/38892227/
智鼠故事 
